Public ** "buy" drug purchase costs or drop more than 30%

The core message: Shenzhen plans to promote reforms in drug procurement, reduce drug inflated prices, and explore drug group procurement models. At yesterday's interpretation of the "Shenzhen implementation of the implementation plan of the pilot reform of the public hospitals pharmaceutical group procurement reform" policy, Li Chuang, head of the Shenzhen Medical Reform Office, said that Shenzhen hopes to pilot the "group purchase" model to achieve a reduction in the total cost of drug procurement in public hospitals in the city by more than 30%. The overall goal is to reduce the proportion of drug revenue to business revenue to 27% by next year.

Shenzhen plans to promote the reform of drug procurement, reduce the high price of drugs, and explore the purchasing model of drug groups. At yesterday's interpretation of the "Shenzhen implementation of the implementation plan of the pilot reform of the public hospitals pharmaceutical group procurement reform" policy, Li Chuang, head of the Shenzhen Medical Reform Office, said that Shenzhen hopes to pilot the "group purchase" model to achieve a reduction in the total cost of drug procurement in public hospitals in the city by more than 30%. The overall goal is to reduce the proportion of drug revenue to business revenue to 27% by next year.

“The total cost of drug procurement in Shenzhen Public Hospital last year was about 7 billion yuan, and it is estimated that this year's expenditure can be reduced by at least 20 billion yuan.” Li Chuang said. The reporter learned that it is expected that preparations for the formulation of supporting plans and the selection of group procurement organizations will be completed by the end of this month, and the first batch of pharmaceutical group purchases will be started.

Drug purchase model reduces costs

Why does Shenzhen want to build its own platform for procurement? Li Chuang explained that Shenzhen's public hospitals currently purchase drugs through the Guangdong Provincial Drug Trading Platform (hereinafter referred to as the provincial platform). Although the overall purchase price is lower than the national level, there is still a phenomenon of drug hyperactivity and there is room for decline.

“The current status quo is that there are tens of thousands of drugs in the provincial platform, and only 1,000 kinds of drugs are commonly used in public hospitals in the city. Due to the wide range of drugs available, it not only causes the purchase of the same drug to be dispersed, but also disguised promotion for pharmaceutical representatives. Leaving a huge space." Li Chuang also said that the province's medical institutions in the provincial trading platform alone purchase orders, bid once a month, resulting in a single purchase volume is dispersed, it is difficult to form a "volume price linked to volume control price" Negotiating power for negotiation.

According to the “plan” implemented by Shenzhen, the procurement model for the pharmaceutical group is to entrust a third-party pharmaceutical group procurement organization to take charge of the unified procurement of clinically used drugs in public hospitals in the city, implement “provisioned procurement”, organize fixed-point production, fixed-point procurement, and negotiate bargaining. , to reduce the circulation of drugs and reduce the cost of drug purchases.

"This move will help public hospitals to more orderly and orderly conduct drug procurement, distribution and clinical drug use, and commercial bribery in the field of pharmaceutical purchases and sales will be effectively contained," said Li Chuang.

The "Proposal" proposed that this time through the group procurement reform pilot, we must make the drug supply prices significantly lower. During the one-year pilot period, the total cost of medicines for centralized procurement in public hospitals in the city will be more than 30% lower than the total cost of medicines purchased on the provincial platform in 2015; at the same time, the level of rational drug use will be increased to 2017. In the year, the proportion of drug revenue from public hospitals in the city to business income dropped to less than 27%.

Hospitals must commit to purchase more than 80%

In addition to the establishment of a unified procurement platform, a major highlight of Shenzhen's drug reform is the development of the "Group Purchasing Catalogue" of public hospitals throughout the city to reduce the total drug procurement of public hospitals in the city and increase the purchase volume of the same drug. The “Group Purchasing Catalogue” required by Shenzhen shall cover the top 80% of the medicines purchased by public hospitals in the city, as well as commonly used low-priced medicines, women's and children's medicines, emergency rescue medicines, and market-shortage medicines, and specify the general use of each medicine. Names, dosage forms, specifications, the catalog is adjusted once a year.

The reporter learned that the “Group Purchasing Catalogue” implements “one product and two regulations”. The types of drugs with the same generic name, injection dosage forms and oral dosage forms should not exceed two kinds, and the prescription formulation should consist of 1-2 kinds of compound preparations, taking into account adults and children. Medications are required, except for the use of other dosage forms and dosage specifications for special medical treatment.

The public hospitals submit annual purchasing volume and pledge to purchase 80% or more of the expected purchase volume. After the total amount of centralized procurement is determined, the Group's procurement organization will conduct fixed-point production and fixed-point procurement, reduce the circulation of medicines, and reduce the cost of drug procurement.

However, drugs that are not yet included in the "Group Purchasing Catalogue" are self-organized by public hospitals but must be filed on the municipal drug administration platform. Li Chuang introduced that this 20 percent self-purchase space is conducive to satisfying multiple levels of drug demand.

"After the implementation of group purchases, the city's public hospital medicines have only one price, namely the purchase price (including the delivery price), and it is also the 'selling price' of hospital drugs." Li Chuang said.

The total purchase cost will be "ceiling"

Shenzhen will select a pharmaceutical company as a third-party group procurement organization. Li Chuang said that after packaging all medicines that need to be purchased in the city's public hospitals for one year, they are collectively referred to their purchases and limit the maximum total purchase cost. The reporter learned that pharmaceutical companies as third-party procurement platforms are still selected.

Li Chuang introduced that in terms of regulatory systems, it is first necessary to formulate a management approach to group procurement catalogs, clarifying the principles, procedures, and supervision measures for drug selection.

At the same time, Shenzhen has formed dozens of municipal public hospitals pharmacy expert committees composed of clinical drug experts and medical experts. The committee is responsible for organizing and adjusting the "Group Purchasing Catalogue". Shenzhen will implement online supervision of drug procurement and develop a public hospital drug administration platform to conduct online supervision of public hospitals on the number and price of drug purchases, timeliness of supply guarantees, and quality and safety.

Explore the "Internet + medicine" model

In addition, Shenzhen will also explore a new model of “Internet + medicine”. According to the "Program", Shenzhen will build a centralized Internet supply platform. The Group's procurement organization will develop a drug internet supply platform, interface with information systems of hospitals, drug production and operation companies, and government-related regulatory agencies to meet order integration, contract management, procurement transactions, settlement payments, distribution management, clinical drug analysis, drug quality evaluation, Enterprise credit rating and other functional requirements.

The supply platform will also publish the information on the general name, dosage form, specification, brand and supply price, production and distribution companies, and the lot number, validity period, and inspection report of each batch of regulatory drugs. Drug information is open and transparent. In addition, Shenzhen will also promote "Internet + drug distribution." The government encourages and supports social forces to provide medicine logistics outsourcing services for medical institutions and provides patients with medicine services such as medicine modulation and drug delivery.

Li Chuang stated that Shenzhen will promote physicians to issue prescriptions in accordance with the generic name of drugs, encourage patients to purchase drugs from social retail pharmacies by prescription, and gradually realize the free circulation of medical institution prescriptions among the designated institutions of the city's medical insurance.